Stefan Stevanović
Impact in
- Immunology top 0.05%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Oncology top 0.5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
Papers in
- Immunology 253
- Immunotherapy and Immune Responses 186
- T-cell and B-cell Immunology 98
- Immune Cell Function and Interaction 74
- Oncology 81
- CAR-T cell therapy research 38
- Cancer Immunotherapy and Biomarkers 29
- Co-authors
- Hans‐Georg Rammensee (135 shared papers)Thomas Friede (4 shared papers)Jutta Bachmann (6 shared papers)Niels Emmerich (3 shared papers)Markus Schirle (15 shared papers)Hubert Kalbacher (14 shared papers)Hans-Georg Rammensee (15 shared papers)Oliver Schoor (16 shared papers)
- Journals
- The Journal of Immunology (17 papers)Blood (16 papers)European Journal of Immunology (15 papers)Immunogenetics (14 papers)Cancer Immunology Immunotherapy (13 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Stefan Stevanović
353 papers receiving 23.3k citations
Stefan Stevanović's Hit Papers
Peers
Comparison fields: 5 of 165
- Immunology 13.3k
- Oncology 5.7k
- Virology 765
- Molecular Biology 10.4k
- Microbiology 876
Countries citing papers authored by Stefan Stevanović
This map shows the geographic impact of Stefan Stevanović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Stevanović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Stevanović more than expected).
Fields of papers citing papers by Stefan Stevanović
This network shows the impact of papers produced by Stefan Stevanović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Stevanović. The network helps show where Stefan Stevanović may publish in the future.
Co-authors
The 25 scholars most cited alongside Stefan Stevanović, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 357 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | SYFPEITHI: database for MHC ligands and peptide motifs Hit paper breakdown → | 1999 | 2026 |
| 2 | MHC ligands and peptide motifs: first listing Hit paper breakdown → | 1995 | 1471 |
| 3 | Actively personalized vaccination trial for newly diagnosed glioblastoma Hit paper breakdown → | 2018 | 764 |
| 4 | Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival Hit paper breakdown → | 2012 | 680 |
| 5 | A vaccine targeting mutant IDH1 induces antitumour immunity Hit paper breakdown → | 2014 | 608 |
| 6 | Dermcidin: a novel human antibiotic peptide secreted by sweat glands Hit paper breakdown → | 2001 | 596 |
| 7 | 2005 | 531 | |
| 8 | 2020 | 443 | |
| 9 | A vaccine targeting mutant IDH1 in newly diagnosed glioma Hit paper breakdown → | 2021 | 330 |
| 10 | 2008 | 322 | |
| 11 | 2001 | 316 | |
| 12 | 1997 | 283 | |
| 13 | 1999 | 270 | |
| 14 | 1998 | 254 | |
| 15 | 1999 | 244 | |
| 16 | 2012 | 236 | |
| 17 | 1998 | 211 | |
| 18 | 2000 | 209 | |
| 19 | 2020 | 203 | |
| 20 | Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes. | 1998 | 195 |
About Stefan Stevanović
Stefan Stevanović is a scholar working on Immunology, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Microbiology, having authored 357 papers that have together received 24.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (186 papers), T-cell and B-cell Immunology (98 papers), vaccines and immunoinformatics approaches (90 papers), Immune Cell Function and Interaction (74 papers), CAR-T cell therapy research (38 papers), Cancer Immunotherapy and Biomarkers (29 papers), Monoclonal and Polyclonal Antibodies Research (29 papers) and Glycosylation and Glycoproteins Research (17 papers). The work is most often cited by research in Immunology (13.3k citations), Oncology (5.7k citations), Virology (765 citations), Molecular Biology (10.4k citations) and Microbiology (876 citations). Stefan Stevanović has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Hans‐Georg Rammensee, Thomas Friede, Jutta Bachmann, Niels Emmerich, Markus Schirle, Hubert Kalbacher, Hans-Georg Rammensee, Oliver Schoor, Günther Jung and Hansjörg Schild. Their work appears in journals such as The Journal of Immunology, Blood, European Journal of Immunology, Immunogenetics and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.